Home



ZADAXIN
(thymosin alpha 1)




ZADAXIN
Bibliography &
Presentations




Medical
Conferences




Contact



Site Map



International
Language Support


   

<< Previous Section Table of Contents Next Section >>

Chemical Properties of Zadaxin

Zadaxin (thymalfasin), originally isolated as a natural substance from thymus tissue, is a pure, synthetic amino-terminal acylated peptide of 28 amino acids (molecular weight 3108; Figure 1). Some early studies utilized a partially purified thymic preparation (thymic fraction 5 or TF5) that contained about 1% thymalfasin; (1,2) however, most studies have utilized synthetic preparations of Zadaxin made by solid phase peptide synthesis. (3)

Figure 1.  Primary structure of thymalfasin

Endogenous thymalfasin can be detected in serum, where levels measured in healthy adults by immunoassays are in the 0.1 to 1 ng/mL range. (4-7) The circulating concentration of thymalfasin tends to be lower in diseased individuals and higher during pregnancy. (8-11) The source and mechanisms of release and regulation of circulating thymalfasin are unknown. Thymalfasin is contained in the sequence of prothymosin, a 126-amino-acid peptide that is found in the cell nucleus (12-16), and that has been examined in terms of potential effects on cell proliferation. (17-19) Thymalfasin, found in highest concentrations in the thymus, has also been found in spleen, lung, kidney, brain, blood, and a number of other tissues. Thymalfasin has amino-acid sequence homology with interferon alpha (IFNα) and members of the glucagon-vasoactive intestinal peptide (VIP)-secretin family of peptides. Although binding of high concentrations of thymalfasin to VIP receptors has been reported (20,21) and thymalfasin has been found to weakly stimulate adenylate cyclase activity, the receptors for thymalfasin are not known. It is possible that thymalfasin has intracellular receptors, as it can fold into a structured helix in organic solvents and thus may cross the membrane unassisted. (22)

 



  Home | Zadaxin | Scientific Papers | Conferences | Contact | Site Map
Copyright © 2003-2004 SciClone Pharmaceuticals International